Scinai Immunotherapeutics (SCNI) EPS (Diluted) (QoQ) (2018 - 2025)
Scinai Immunotherapeutics (SCNI) EPS (Diluted) (QoQ) (2018 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Scinai Immunotherapeutics | 352,860.00 | -3.11 Bn | -1.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 29.06% |
| Mar 31, 2025 | 56.88% |
| Dec 31, 2024 | -6.59% |
| Sep 30, 2024 | 58.86% |
| Jun 30, 2024 | -118.61% |
| Mar 31, 2024 | 211.81% |
| Dec 31, 2023 | -80,029,865.38% |
| Sep 30, 2023 | -100.00% |
| Jun 30, 2023 | 6.24% |
| Mar 31, 2023 | 110.01% |
| Dec 31, 2022 | -195,313,774.68% |
| Sep 30, 2022 | 100.00% |
| Jun 30, 2022 | -100.27% |
| Mar 31, 2022 | -109.16% |
| Dec 31, 2021 | 3,751.67% |
| Sep 30, 2021 | 56.84% |
| Jun 30, 2021 | -594.93% |
| Mar 31, 2021 | 94.62% |
| Dec 31, 2020 | -135.88% |
| Sep 30, 2019 | -92.31% |